Chong Kun Dang Receives Approval for Telminuvo: Investment Opportunity or Risk?
Chong Kun Dang’s New Hypertension Drug Telminuvo Approved: Is it an Investment Opportunity? Chong Kun Dang has secured a new growth engine with the domestic approval of Telminuvo (CKD-828). However, potential risks exist, including recent sluggish performance and intensified market competition. This article analyzes the implications of Telminuvo’s approval and key factors investors should consider, … Read more